Homologous Recombination Deficiency Scar: Mutations and Beyond-Implications for Precision Oncology.
DNA repair
biomarkers
cancer
homologous recombination
homologous recombination deficiency
homologous recombination deficiency scar
precision oncology
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
27 Aug 2022
27 Aug 2022
Historique:
received:
05
07
2022
revised:
22
08
2022
accepted:
23
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
10
9
2022
Statut:
epublish
Résumé
Homologous recombination deficiency (HRD) is a prevalent in approximately 17% of tumors and is associated with enhanced sensitivity to anticancer therapies inducing double-strand DNA breaks. Accurate detection of HRD would therefore allow improved patient selection and outcome of conventional and targeted anticancer therapies. However, current clinical assessment of HRD mainly relies on determining germline
Identifiants
pubmed: 36077694
pii: cancers14174157
doi: 10.3390/cancers14174157
pmc: PMC9454578
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : European Research Council
ID : ERC-ADG-2015, no. 694812
Pays : International
Références
Hum Cell. 2022 Jan;35(1):199-213
pubmed: 34628623
BMC Pharmacol. 2011 Jul 19;11:7
pubmed: 21771338
Nat Commun. 2020 May 20;11(1):2517
pubmed: 32433464
Nature. 2012 Jan 18;481(7381):287-94
pubmed: 22258607
Science. 2022 Apr 22;376(6591):
pubmed: 35949260
Breast Cancer Res. 2014 Jun 03;16(3):211
pubmed: 25093514
Cancer Immunol Immunother. 2019 Oct;68(10):1621-1633
pubmed: 31549213
Oncotarget. 2016 Mar 22;7(12):13587-98
pubmed: 26871470
J Thorac Oncol. 2013 Mar;8(3):279-86
pubmed: 23399959
Ann Oncol. 2018 May 1;29(5):1203-1210
pubmed: 29635390
Oncotarget. 2018 Apr 6;9(26):18198-18213
pubmed: 29719599
Gastroenterology. 2021 May;160(6):2119-2132.e9
pubmed: 33524400
Biomark Res. 2015 May 01;3:9
pubmed: 26015868
Nat Commun. 2020 Nov 4;11(1):5584
pubmed: 33149131
Lancet. 2017 Oct 28;390(10106):1949-1961
pubmed: 28916367
NPJ Breast Cancer. 2019 Aug 8;5:23
pubmed: 31428676
Clin Transl Radiat Oncol. 2019 Jan 18;15:62-69
pubmed: 30734002
Mol Oncol. 2011 Aug;5(4):387-93
pubmed: 21821475
Lancet Oncol. 2019 May;20(5):636-648
pubmed: 30948273
Front Genet. 2021 Nov 23;12:780293
pubmed: 34887904
NPJ Breast Cancer. 2018 Jul 2;4:16
pubmed: 29978035
Genes (Basel). 2018 Dec 13;9(12):
pubmed: 30551670
Breast Cancer Res Treat. 2015 Jun;151(3):629-38
pubmed: 26006067
Chromosoma. 1979 Aug;73(3):275-86
pubmed: 510071
Cell. 2012 May 25;149(5):979-93
pubmed: 22608084
Cancer Res. 2012 Nov 1;72(21):5454-62
pubmed: 22933060
Nature. 2015 May 28;521(7553):489-94
pubmed: 26017449
Sci Rep. 2020 Feb 17;10(1):2757
pubmed: 32066851
Mol Cancer Ther. 2014 Nov;13(11):2501-14
pubmed: 25193512
Nat Commun. 2019 Jul 5;10(1):2969
pubmed: 31278357
Orphanet J Rare Dis. 2016 Nov 25;11(1):159
pubmed: 27884168
Clin Cancer Res. 2016 Aug 1;22(15):3764-73
pubmed: 26957554
Breast Cancer Res. 2014 Dec 05;16(6):475
pubmed: 25475740
Clin Cancer Res. 2015 Jul 1;21(13):2984-92
pubmed: 25805800
Nat Rev Cancer. 2012 Oct;12(10):663-70
pubmed: 22972457
JCO Precis Oncol. 2018;2018:
pubmed: 30234181
Nature. 2015 Feb 26;518(7540):495-501
pubmed: 25719666
Br J Cancer. 2012 Nov 6;107(10):1776-82
pubmed: 23047548
Nat Cancer. 2020 Feb;1(2):249-263
pubmed: 32118208
Cell. 2016 Mar 24;165(1):35-44
pubmed: 26997480
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
BMC Med. 2021 Sep 1;19(1):190
pubmed: 34465315
J Clin Oncol. 2015 Jun 10;33(17):1895-901
pubmed: 25847929
J Natl Cancer Inst. 2016 Oct 5;109(1):
pubmed: 27707838
Nature. 2016 Mar 3;531(7592):47-52
pubmed: 26909576
BMC Cell Biol. 2001;2:11
pubmed: 11472631
Leukemia. 2017 Oct;31(10):2048-2056
pubmed: 28196983
EMBO Mol Med. 2019 Jul;11(7):e9982
pubmed: 31273933
Nature. 2022 Jun;606(7916):984-991
pubmed: 35705804
Nat Rev Mol Cell Biol. 2017 Aug;18(8):495-506
pubmed: 28512351
Annu Rev Biochem. 2014;83:519-52
pubmed: 24606147
Commun Biol. 2020 Aug 3;3(1):421
pubmed: 32747711
Cancer Res. 2001 Jun 15;61(12):4842-50
pubmed: 11406561
Genes (Basel). 2021 Aug 31;12(9):
pubmed: 34573351
J Pers Med. 2021 Jun 28;11(7):
pubmed: 34203281
Curr Med Chem. 2017;24(15):1586-1606
pubmed: 27978798
Nat Cancer. 2021 Dec;1(12):1188-1203
pubmed: 33834176
N Engl J Med. 2019 Dec 19;381(25):2416-2428
pubmed: 31851799
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Ann Oncol. 2018 Mar 1;29(3):654-660
pubmed: 29293876
Front Cell Dev Biol. 2020 Sep 09;8:564601
pubmed: 33015058
Nat Rev Cancer. 2021 Oct;21(10):619-637
pubmed: 34316057
Mol Cancer Ther. 2021 Dec;20(12):2372-2383
pubmed: 34625504
Chem Res Toxicol. 2022 Feb 21;35(2):275-282
pubmed: 35050609
Br J Cancer. 2022 Jan;126(1):120-128
pubmed: 34732853
Nature. 2019 Nov;575(7781):210-216
pubmed: 31645765
Science. 2016 Mar 25;351(6280):1463-9
pubmed: 26940869
Nat Cell Biol. 2009 Jun;11(6):761-8
pubmed: 19465921
Cancer Treat Rev. 2019 Nov;80:101909
pubmed: 31629204
EMBO J. 1998 Sep 15;17(18):5497-508
pubmed: 9736627
Front Genet. 2021 Aug 02;12:723847
pubmed: 34408777
Cancer Discov. 2017 Sep;7(9):984-998
pubmed: 28588062
Eur J Cancer. 2021 Dec;159:283-295
pubmed: 34837859
Clin Cancer Res. 2017 Jun 1;23(11):2617-2629
pubmed: 28572256
PLoS One. 2019 Apr 25;14(4):e0215381
pubmed: 31022191
J Clin Oncol. 2020 Dec 20;38(36):4274-4282
pubmed: 33119476
Ann Oncol. 2020 Nov;31(11):1518-1525
pubmed: 32798689
Clin Cancer Res. 2013 Jul 1;19(13):3474-84
pubmed: 23633455
Clin Cancer Res. 2020 Jul 1;26(13):3239-3247
pubmed: 32444418
Breast Cancer Res Treat. 2009 May;115(2):359-63
pubmed: 18649131
Nat Commun. 2015 Oct 29;6:8683
pubmed: 26511885
Semin Cell Dev Biol. 2022 Mar;123:110-114
pubmed: 33589336
Lancet Oncol. 2017 Jan;18(1):75-87
pubmed: 27908594
Int J Mol Sci. 2019 Aug 24;20(17):
pubmed: 31450627
Cytogenet Genome Res. 2004;104(1-4):333-40
pubmed: 15162061
J Clin Oncol. 2010 Mar 1;28(7):1145-53
pubmed: 20100965
Cancer Discov. 2012 Apr;2(4):366-375
pubmed: 22576213
Cancer Discov. 2017 Sep;7(9):1006-1017
pubmed: 28450425
Mol Cell Biol. 2002 Oct;22(20):6971-8
pubmed: 12242278
Cancers (Basel). 2021 May 07;13(9):
pubmed: 34067105
Sci Transl Med. 2017 Jun 7;9(393):
pubmed: 28592566
Trends Cancer. 2022 Mar;8(3):174-189
pubmed: 35000881
ESMO Open. 2021 Jun;6(3):100144
pubmed: 34015643
Nat Commun. 2017 Nov 24;8(1):1751
pubmed: 29170499
J Clin Oncol. 2018 Jun 10;36(17):1685-1694
pubmed: 29489427
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Nat Genet. 2017 Oct;49(10):1476-1486
pubmed: 28825726
Int J Cancer. 2016 Feb 15;138(4):891-900
pubmed: 26317927
Nat Rev Cancer. 2016 Feb;16(2):110-20
pubmed: 26775620
Cell Mol Life Sci. 2020 Jan;77(1):3-18
pubmed: 31748913
Cancers (Basel). 2021 Feb 24;13(5):
pubmed: 33668244
Nature. 2008 Feb 28;451(7182):1116-20
pubmed: 18264087
Eur J Cancer. 2017 Nov;86:5-14
pubmed: 28950147
Br J Cancer. 2016 May 10;114(10):1071-7
pubmed: 27070712
Mod Pathol. 2021 Jun;34(6):1185-1193
pubmed: 33462368
Nat Commun. 2020 May 29;11(1):2662
pubmed: 32471999
Oncogene. 2022 Jun;41(26):3498-3506
pubmed: 35662281
J Clin Oncol. 2020 May 1;38(13):1378-1388
pubmed: 31976786
Gynecol Oncol. 2019 May;153(2):217-222
pubmed: 30803719
Cancer Immunol Immunother. 2022 Apr;71(4):943-951
pubmed: 34533610
J Biol Chem. 2000 Aug 4;275(31):23899-903
pubmed: 10843985
Nat Genet. 2019 May;51(5):912-919
pubmed: 30988514
J Natl Cancer Inst. 2018 Jul 1;110(7):704-713
pubmed: 29788099
Eur Urol. 2019 Oct;76(4):452-458
pubmed: 30797618
Genome Biol. 2019 Nov 14;20(1):240
pubmed: 31727117
Front Pediatr. 2020 Oct 23;8:570084
pubmed: 33194896
Nucleic Acids Res. 2021 May 7;49(8):4239-4257
pubmed: 33744950
Radiother Oncol. 2017 Sep;124(3):513-520
pubmed: 28502472
Nat Rev Mol Cell Biol. 2019 Nov;20(11):698-714
pubmed: 31263220
Clin Cancer Res. 2021 Oct 15;27(20):5681-5687
pubmed: 34380641
J Pharmacol Exp Ther. 2015 Jun;353(3):446-57
pubmed: 25758918
Cancer Treat Rev. 2007 Feb;33(1):9-23
pubmed: 17084534
Nat Med. 2017 Apr;23(4):517-525
pubmed: 28288110